AKT1 and neoplasm: These observations make sense, as Quayle et al. demonstrated that mutations of the PIK3R1 gene promote the formation and development of gliomas and that GBM patients whose tumours carry mutant PIK3R1 alleles may benefit from treatment with inhibitors of Protein kinase B (PKB)/Akt [33].